Oncology

At the AACR 2025 Annual Meeting in Chicago, new data presented on the investigational agent zoldonrasib showed encouraging clinical activity in patients with non-small cell lung cancer (NSCLC) harboring the KRAS G12D mutation.

Timely lung cancer diagnosis and treatment are essential for improved survival, but new research shows that patients with suspicious lung nodules continue to experience critical delays at multiple stages of care.

Patients undergoing spinal surgery for metastatic disease face a heightened risk of nonroutine discharge, often leading to increased healthcare costs and higher readmission rates.

A recent study offers fresh insights into how heart rate variability (HRV) measures, both linear and nonlinear, can help detect autonomic nervous system dysfunction in fibromyalgia (FM), a chronic condition marked by widespread pain, fatigue, and mood disturbances.

In a real-world study examining neoadjuvant chemotherapy for human epidermal growth factor receptor 2-positive (HER2+) breast cancer, researchers have identified key predictors of treatment response and long-term survival, providing critical insights for oncologists managing this aggressive disease.

In a significant update for head and neck oncology care, new clinical insights into transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma (OPC) aim to guide U.S. physicians in tailoring treatment plans through a multidisciplinary lens.

Sexual health after breast cancer remains one of the least addressed yet deeply impactful aspects of survivorship, according to a new qualitative study that gives voice to the intimate challenges faced by women in the aftermath of treatment.

Pediatric cancer care, medical tourism, and cross-border access to healthcare converge in a newly published 10-year review highlighting international families traveling to the United States for treatment of serious childhood malignancies and blood disorders.